Laboratory Research Compound Overview
Vriligy 60 mg is a selective serotonin reuptake inhibitor (SSRI) manufactured by Centurion Laboratories for controlled laboratory research applications. This pharmaceutical-grade compound contains dapoxetine as the active substance and is exclusively intended for in-vitro scientific investigation. Researchers at Stroid UK Shop can study this compound’s pharmacokinetic properties, receptor binding characteristics, and molecular interactions in controlled laboratory environments. The formulation provides researchers with standardised dosing capabilities for consistent experimental protocols across multiple research sessions.
Scientific Applications in Research
Dapoxetine research encompasses multiple areas of pharmacological investigation, particularly its effects on serotonin reuptake mechanisms and neurotransmitter pathway modulation. Laboratory studies examine this compound’s binding affinity at serotonin transporters, its selectivity profiles compared to other SSRI compounds, and its metabolic pathways through liver enzyme systems. Research teams investigating selective serotonin reuptake modulators utilise this compound to evaluate pharmacokinetic parameters including absorption rates, distribution patterns, and elimination half-life characteristics. Scientists also study its interactions with various receptor subtypes and its potential modulatory effects on neurochemical signalling cascades in cellular research models.
Research Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Dapoxetine hydrochloride |
| Strength | 60 mg per unit |
| Manufacturer | Centurion Laboratories |
| Form | Oral research tablets |
| Storage | Room temperature, dry conditions |
| Chemical Class | Selective serotonin reuptake inhibitor |
This research-grade formulation enables precise experimental dosing and consistent analytical results across laboratory studies. Unlike research chemicals from selective androgen receptor modulators or peptide research compounds, dapoxetine studies focus on neurotransmitter system modulation and SSRI mechanism evaluation in controlled research environments.
Regulatory Compliance
This product is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. It is not approved for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must comply with all applicable laboratory safety protocols and regulatory requirements when handling this compound. All research activities must be conducted in appropriately equipped laboratory facilities with proper safety equipment and waste disposal procedures following institutional guidelines.
